As Kinder Morgan (KMI) Share Price Declined, Holder Jacobus Wealth Management Cut Position by $335,350; Gruss & Co Boosted Its Biogen (BIIB) Position by $1.57 Million

February 21, 2018 - By Louis Casey

Gruss & Co Inc increased its stake in Biogen Inc (BIIB) by 125% based on its latest 2017Q3 regulatory filing with the SEC. Gruss & Co Inc bought 5,000 shares as the company’s stock declined 13.45% while stock markets rallied. The institutional investor held 9,000 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $2.82 million, up from 4,000 at the end of the previous reported quarter. Gruss & Co Inc who had been investing in Biogen Inc for a number of months, seems to be bullish on the $61.01 billion market cap company. The stock increased 0.32% or $0.925 during the last trading session, reaching $288.375. About 741,114 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since February 21, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

Jacobus Wealth Management Inc decreased its stake in Kinder Morgan Inc (KMI) by 10.14% based on its latest 2017Q3 regulatory filing with the SEC. Jacobus Wealth Management Inc sold 17,650 shares as the company’s stock declined 10.34% while stock markets rallied. The institutional investor held 156,406 shares of the public utilities company at the end of 2017Q3, valued at $3.00 million, down from 174,056 at the end of the previous reported quarter. Jacobus Wealth Management Inc who had been investing in Kinder Morgan Inc for a number of months, seems to be less bullish one the $37.35B market cap company. The stock decreased 0.41% or $0.07 during the last trading session, reaching $16.93. About 3.86M shares traded. Kinder Morgan, Inc. (NYSE:KMI) has risen 13.09% since February 21, 2017 and is uptrending. It has underperformed by 3.61% the S&P500.

Investors sentiment decreased to 0.77 in Q3 2017. Its down 0.13, from 0.9 in 2017Q2. It turned negative, as 70 investors sold KMI shares while 353 reduced holdings. 69 funds opened positions while 257 raised stakes. 1.31 billion shares or 2.89% more from 1.27 billion shares in 2017Q2 were reported. Moreover, Qs Invsts Ltd Limited Liability Company has 0.03% invested in Kinder Morgan, Inc. (NYSE:KMI) for 219,039 shares. Voloridge Investment Lc has invested 0.05% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). 12,763 are held by Gamco Investors Inc Et Al. 730,595 were reported by Td Asset Mgmt. Gamble Jones Inv Counsel has 20,572 shares for 0.04% of their portfolio. Axa holds 0.03% or 360,512 shares in its portfolio. Middleton Company Ma invested 0.05% in Kinder Morgan, Inc. (NYSE:KMI). Caz Invests Limited Partnership holds 1% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI) for 42,390 shares. Swift Run Llc reported 28,528 shares. Bluecrest Capital Mgmt Limited reported 0.05% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI). Swiss State Bank invested in 7.40 million shares or 0.16% of the stock. Bnp Paribas Arbitrage stated it has 1.32 million shares. Thompson Siegel And Walmsley Limited Co holds 0% or 285 shares in its portfolio. Texan Mgmt owns 25,874 shares or 0.33% of their US portfolio. 13,874 are owned by Capital Innovations Ltd Liability.

Analysts await Kinder Morgan, Inc. (NYSE:KMI) to report earnings on April, 18. They expect $0.20 EPS, up 17.65% or $0.03 from last year’s $0.17 per share. KMI’s profit will be $441.22 million for 21.16 P/E if the $0.20 EPS becomes a reality. After $0.21 actual EPS reported by Kinder Morgan, Inc. for the previous quarter, Wall Street now forecasts -4.76% negative EPS growth.

Among 23 analysts covering Kinder Morgan (NYSE:KMI), 14 have Buy rating, 0 Sell and 9 Hold. Therefore 61% are positive. Kinder Morgan had 75 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Thursday, October 22 with “Overweight”. Argus Research downgraded the stock to “Hold” rating in Thursday, December 3 report. RBC Capital Markets maintained it with “Outperform” rating and $29 target in Thursday, December 3 report. Jefferies maintained the shares of KMI in report on Monday, October 16 with “Hold” rating. The company was initiated on Friday, April 21 by Macquarie Research. The stock of Kinder Morgan, Inc. (NYSE:KMI) earned “Buy” rating by BMO Capital Markets on Tuesday, June 20. The firm has “Neutral” rating given on Friday, April 1 by Piper Jaffray. JP Morgan maintained Kinder Morgan, Inc. (NYSE:KMI) rating on Monday, February 12. JP Morgan has “Overweight” rating and $21 target. The firm earned “Buy” rating on Sunday, August 16 by Goldman Sachs. On Monday, October 24 the stock rating was upgraded by Raymond James to “Strong Buy”.

Jacobus Wealth Management Inc, which manages about $844.49 million and $381.97 million US Long portfolio, upped its stake in Wisdomtree Us Smallcap Div Etf (DES) by 4,890 shares to 107,348 shares, valued at $9.02M in 2017Q3, according to the filing. It also increased its holding in Spdr S&P 500 Etf (SPY) by 1,258 shares in the quarter, for a total of 80,708 shares, and has risen its stake in Calamos Convertible & High Income Cef (CHY).

Since January 9, 2018, it had 0 insider purchases, and 1 sale for $1.92 million activity.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 24 have Buy rating, 0 Sell and 9 Hold. Therefore 73% are positive. Biogen Idec Inc. had 113 analyst reports since July 23, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of BIIB in report on Thursday, January 18 with “Buy” rating. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Wednesday, October 25 by H.C. Wainwright. The stock of Biogen Inc. (NASDAQ:BIIB) earned “Buy” rating by Citigroup on Tuesday, February 7. The firm has “Hold” rating by Stifel Nicolaus given on Tuesday, July 25. Mizuho upgraded the stock to “Buy” rating in Tuesday, October 17 report. Jefferies maintained the stock with “Hold” rating in Wednesday, October 5 report. The firm has “Market Perform” rating by Leerink Swann given on Thursday, March 16. As per Friday, August 25, the company rating was maintained by Robert W. Baird. Atlantic Securities initiated the shares of BIIB in report on Friday, December 18 with “Overweight” rating. The firm has “Buy” rating given on Wednesday, December 20 by Credit Suisse.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>